Publication | Closed Access

Enhanced preclinical efficacy of tamoxifen developed as alginate–cysteine/disulfide bond reduced albumin nanoparticles

NanomedicineMedicinal ChemistryEngineeringTherapeutic NanomaterialsMedicineEnhanced Preclinical EfficacyPharmaceutical NanotechnologyDrug Delivery SystemsBreast CancerNano-drug DeliveryBiomedical EngineeringAlbumin NanoparticlesPharmacologyProtein NanoparticlesAlginate–cysteine/disulfide Bond